Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lim

Showing results (41-50 of 468) with videos related to

Pageof 47
Sort By:
Current Treatment Options in Oncology|August 9, 2017
Clinical Trials Investigating Immune Checkpoint Blockade in GlioblastomaRussell Maxwell, Christopher M Jackson, Michael Lim
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Current State of Immune-Based Therapies for GlioblastomaMichael Lim, Michael Weller, E Antonio Chiocca
Immunity|May 5, 2025
Complex neural-immune interactions shape glioma immunotherapyKun-Wei Song, Michael Lim, Michelle Monje
World Journal of Gastrointestinal Pharmacology and Therapeutics|February 21, 2017
Role of clinical pathway in improving the quality of care for patients with faecal incontinence: A randomised trialZeiad I Hussain, Michael Lim, Stevan Stojkovic
Neuro-Oncology|November 2, 2022
Updates in intraoperative strategies for enhancing intra-axial brain tumor controlAdela Wu, Janet Yuling Wu, Michael Lim
Nature Immunology|July 31, 2019
Mechanisms of immunotherapy resistance: lessons from glioblastomaChristopher M Jackson, John Choi, Michael Lim
Neurosurgery Clinics of North America|December 1, 2009
Mechanisms of local immunoresistance in gliomaEmilia Albesiano, James E Han, Michael Lim
Current Treatment Options in Oncology|July 23, 2016
Controversies in the Therapy of Brain Metastases: Shifting Paradigms in an Era of Effective Systemic Therapy and Longer-Term SurvivorshipColette J Shen, Michael Lim, Lawrence R Kleinberg
Nature Reviews. Clinical Oncology|April 13, 2018
Current state of immunotherapy for glioblastomaMichael Lim, Yuanxuan Xia, Chetan Bettegowda, et al.
Immunotherapy|February 19, 2013
Vaccine strategies for glioblastoma: progress and future directionsChristopher Jackson, Jacob Ruzevick, Henry Brem, et al.
Pageof 47

Showing results (41-50 of 468) with videos related to

Sort By:
Pageof 47
Current Treatment Options in Oncology|August 9, 2017
Clinical Trials Investigating Immune Checkpoint Blockade in GlioblastomaRussell Maxwell, Christopher M Jackson, Michael Lim
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Current State of Immune-Based Therapies for GlioblastomaMichael Lim, Michael Weller, E Antonio Chiocca
Immunity|May 5, 2025
Complex neural-immune interactions shape glioma immunotherapyKun-Wei Song, Michael Lim, Michelle Monje
World Journal of Gastrointestinal Pharmacology and Therapeutics|February 21, 2017
Role of clinical pathway in improving the quality of care for patients with faecal incontinence: A randomised trialZeiad I Hussain, Michael Lim, Stevan Stojkovic
Neuro-Oncology|November 2, 2022
Updates in intraoperative strategies for enhancing intra-axial brain tumor controlAdela Wu, Janet Yuling Wu, Michael Lim
Nature Immunology|July 31, 2019
Mechanisms of immunotherapy resistance: lessons from glioblastomaChristopher M Jackson, John Choi, Michael Lim
Neurosurgery Clinics of North America|December 1, 2009
Mechanisms of local immunoresistance in gliomaEmilia Albesiano, James E Han, Michael Lim
Current Treatment Options in Oncology|July 23, 2016
Controversies in the Therapy of Brain Metastases: Shifting Paradigms in an Era of Effective Systemic Therapy and Longer-Term SurvivorshipColette J Shen, Michael Lim, Lawrence R Kleinberg
Nature Reviews. Clinical Oncology|April 13, 2018
Current state of immunotherapy for glioblastomaMichael Lim, Yuanxuan Xia, Chetan Bettegowda, et al.
Immunotherapy|February 19, 2013
Vaccine strategies for glioblastoma: progress and future directionsChristopher Jackson, Jacob Ruzevick, Henry Brem, et al.
Pageof 47